Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lucid Scientific

Explore full profile

Designs and develops the RESIPHER series of real-time cellular activity monitors

Atlanta, United StatesFounded 2012Biotech & Life Sciences
Valuation $25–50M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Lucid Scientific and the history behind them.

About Lucid Scientific

Lucid Scientific operates in the biotechnology sector, specializing in innovative cell culture monitoring solutions. The company's flagship product, RESIPHER, is a handheld device designed to continuously measure oxygen consumption in standard multiwell plates, providing real-time insights directly from incubators. This technology serves researchers and laboratories of various sizes, offering configurations in 4-channel and 32-channel formats, with the ability to connect up to 8 devices on a single hub. The RESIPHER system features ultra-sensitive dissolved oxygen sensors and dynamic vertical micro movements to scan oxygen gradients formed by metabolically active cells, enabling unprecedented insights into cellular responses. Lucid Scientific also offers cloud-connected hubs and a cross-platform app, Lucid Lab, for managing experiments, monitoring performance, and visualizing data from anywhere. The company's business model revolves around selling these advanced monitoring devices and providing a subscription-based service for data management and analysis through their cloud platform. Lucid Scientific generates revenue through the sale of RESIPHER devices, subscriptions to their cloud services, and potential custom system integrations via their open API. The company primarily serves academic research institutions, pharmaceutical companies, and biotech firms looking to enhance their cell culture analysis capabilities.

Source: Dealroom company data

At a glance

Founded
2012
Headquarters
Atlanta, United States
Sector
Biotech & Life Sciences

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Georgia Research Alliance
  • GRA Venture Fund
  • Dynamk Capital

Series A1 investor entered at this stage

  • IAG Capital Partners
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States86.7%
🇬🇧 United Kingdom6.7%
🇩🇪 Germany6.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Lucid Scientific on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lucid Scientific on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.